MDRI – New Clinical Trials for Psoriasis and Eczema

MDRI adds several new clinical trials for Psoriasis and Eczema

We are actively seeking participants. Contact us if you need more information on any of our clinical research studies.   For further information on all clinical trials, visit our Clinical Trials page.

Eligibility – Psoriasis

Moderate to Severe Plaque Type Psoriasis
Ages:  18 and older
Both Male and Female
New Clinical Trial additions:

  • Sandoz GP17-301
  • Xenoport, Inc. – XP-H-093
  • M518101-US03
  • VIP 814278


Eligibility – Atopic Dermatitis (Eczema)

Ages:  2 and older
Both Male and Females
New Clinical Trial additions:

  • Anacor – AN2728-AD